Clinical trial

Study To Compare Single Dose Of Three Modified Release Formulations Of PF-04937319 With Immediate Release Material-Sparing-Tablet (IR MST) Formulation Previously Studied In Adults With Type 2 Diabetes Mellitus.

NCT02206607

Study summary

ClinicalTrials.gov

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE1

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

4 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention PF-04937319 IR MST Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention PF-04937319 MR 1 Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention PF-04937319 MR 2 Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention PF-04937319 MR 3 Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2014-09-01

PhasePHASE1

Conditions

Type 2 Diabetes Mellitusverified · MONDO: type 2 diabetes mellitus

Interventions

PF-04937319 IR MSTDRUG

PF-04937319 MR 1DRUG

PF-04937319 MR 2DRUG

PF-04937319 MR 3DRUG

Sponsors & collaborators

Pfizerlead sponsor

Mapped research locations

San AntonioTexas, United States1 High PointNorth Carolina, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02206607 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.